VHL and neoplasm: The inactivation of the Von Hippel–Lindau Tumor Suppressor (VHL) gene and the activation of Hypoxia-Inducible Factor (HIF) promote the production of VEGF, while sunitinib blocks this process and plays an anti-tumor role [49].